This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2008 Jun;7(6):474-5.

doi: 10.1016/S1474-4422(08)70099-1.

Non-autonomous cell death in Parkinson's disease

PMID: 18485311
PMCID: PMC4505358
DOI: 10.1016/S1474-4422(08)70099-1

Non-autonomous cell death in Parkinson's disease

Ted M Dawson. Lancet Neurol. 2008 Jun.

. 2008 Jun;7(6):474-5.

doi: 10.1016/S1474-4422(08)70099-1.

Author

PMID: 18485311
PMCID: PMC4505358
DOI: 10.1016/S1474-4422(08)70099-1

No abstract available

PubMed Disclaimer

Similar articles

Research in motion: the enigma of Parkinson's disease pathology spread.
Brundin P, Li JY, Holton JL, Lindvall O, Revesz T. Brundin P, et al. Nat Rev Neurosci. 2008 Oct;9(10):741-5. doi: 10.1038/nrn2477. Epub 2008 Sep 4. Nat Rev Neurosci. 2008. PMID: 18769444 Review.
Activated microglial cells and complement factors are unrelated to cortical Lewy bodies.
Rozemuller AJ, Eikelenboom P, Theeuwes JW, Jansen Steur EN, de Vos RA. Rozemuller AJ, et al. Acta Neuropathol. 2000 Dec;100(6):701-8. doi: 10.1007/s004010000225. Acta Neuropathol. 2000. PMID: 11078223
Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.
De Lella Ezcurra AL, Chertoff M, Ferrari C, Graciarena M, Pitossi F. De Lella Ezcurra AL, et al. Neurobiol Dis. 2010 Mar;37(3):630-40. doi: 10.1016/j.nbd.2009.11.018. Epub 2009 Dec 5. Neurobiol Dis. 2010. PMID: 19969084
A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
Greffard S, Verny M, Bonnet AM, Seilhean D, Hauw JJ, Duyckaerts C. Greffard S, et al. Neurobiol Aging. 2010 Jan;31(1):99-103. doi: 10.1016/j.neurobiolaging.2008.03.015. Epub 2008 May 23. Neurobiol Aging. 2010. PMID: 18457903
Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients.
Cooper O, Astradsson A, Hallett P, Robertson H, Mendez I, Isacson O. Cooper O, et al. J Neurol. 2009 Aug;256 Suppl 3:310-6. doi: 10.1007/s00415-009-5242-z. J Neurol. 2009. PMID: 19711122 Review.

See all similar articles

Cited by

Anti-Inflammatory and Neuroprotective Effects of PGE₂ EP4 Signaling in Models of Parkinson's Disease.
Pradhan SS, Salinas K, Garduno AC, Johansson JU, Wang Q, Manning-Bog A, Andreasson KI. Pradhan SS, et al. J Neuroimmune Pharmacol. 2017 Jun;12(2):292-304. doi: 10.1007/s11481-016-9713-6. Epub 2016 Oct 12. J Neuroimmune Pharmacol. 2017. PMID: 27734267 Free PMC article.
Pathways towards an effective immunotherapy for Parkinson's disease.
Hutter-Saunders JA, Mosley RL, Gendelman HE. Hutter-Saunders JA, et al. Expert Rev Neurother. 2011 Dec;11(12):1703-15. doi: 10.1586/ern.11.163. Expert Rev Neurother. 2011. PMID: 22091596 Free PMC article. Review.
Immunotherapy for Parkinson's disease.
Schwab AD, Thurston MJ, Machhi J, Olson KE, Namminga KL, Gendelman HE, Mosley RL. Schwab AD, et al. Neurobiol Dis. 2020 Apr;137:104760. doi: 10.1016/j.nbd.2020.104760. Epub 2020 Jan 21. Neurobiol Dis. 2020. PMID: 31978602 Free PMC article. Review.
Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis.
Zhang X, Zhang Y, Li R, Zhu L, Fu B, Yan T. Zhang X, et al. Aging (Albany NY). 2020 May 19;12(10):9405-9426. doi: 10.18632/aging.103215. Epub 2020 May 19. Aging (Albany NY). 2020. PMID: 32432571 Free PMC article.
Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse model.
Kim SJ, Ryu MJ, Han J, Jang Y, Lee MJ, Ju X, Ryu I, Lee YL, Oh E, Chung W, Heo JY, Kweon GR. Kim SJ, et al. Lab Invest. 2019 Sep;99(9):1389-1399. doi: 10.1038/s41374-019-0254-5. Epub 2019 May 1. Lab Invest. 2019. PMID: 31043679

See all "Cited by" articles

References

1. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med. 2008 published online Apr 6. DOI:10.1038/nm1747. - PubMed
1. Li JY, Englund E, Holton JL, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med. 2008 published online Apr 6. DOI:10.1038/nm1746. - PubMed
1. Mendez I, Vinuela A, Astradsson A, et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med. 2008 published online Apr 6. DOI:10.1038/nm1752. - PMC - PubMed
1. Tabar V, Tomishima M, Panagiotakos G, Wakayama S, Menon J, Chan B, et al. Therapeutic cloning in individual parkinsonian mice. Nat Med. 2008;14:379–81. - PMC - PubMed
1. Liberatore GT, Jackson-Lewis V, Vukosavic S, et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med. 1999;5:1403–09. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

P50 NS038377/NS/NINDS NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information